Artelo Biosciences, Inc. - ARTL

About Gravity Analytica
Recent News
- 03.31.2025 - Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025
- 03.03.2025 - Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results
- 02.14.2025 - Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®
- 02.11.2025 - Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
- 01.13.2025 - Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12
- 12.09.2024 - Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia
- 11.18.2024 - Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
- 11.13.2024 - Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
- 11.13.2024 - Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
- 11.12.2024 - Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Recent Filings
- 03.20.2025 - S-8 Securities to be offered to employees in employee benefit plans
- 03.03.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
- 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
- 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
- 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
- 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
- 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
- 12.20.2024 - 8-K Current report